Antibiotic maker Targanta aims for $86.3M IPO
Targanta Therapeutics, a Cambridge, Mass. drug developer at work on a new generation of antibiotics, hopes to raise $86.3 million in an initial offering, according to an SEC filing. The company didn’t specify how many shares it plans to offer or what price it hopes… Continue Reading